Status:
UNKNOWN
To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
50-70 years
Brief Summary
The purpose of this study is to identify genetic determinants of susceptibility to liver cirrhosis and hepatocellular carcinoma. It will assist in predicting individual risks of disease progression an...
Detailed Description
Hepatocellular carcinoma (HCC) usually occurs in cirrhotic liver. Only 10-30% of HCC occur in non-cirrhotic liver. It has been suggested that etiological factors may differ for HCC which develop in ci...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Clinical diagnosis of hepatocellular carcinoma
- restrict the casual agent of liver disease to viral infection
- Exclusion criteria:
- the casual aget of liver disease is not viral infection, such as alcohol abuse
Exclusion
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00709085
Start Date
April 1 2008
End Date
December 1 2009
Last Update
November 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan